Last updated:
On June 1, 2012, Smith & Nephew, an orthopedic firm headquartered in the U.K., issued a press release stating that the company is voluntarily recalling an optional metal liner used in its all-metal hip system, the R3 Acetabular System. According to the company, since the recalled metal hip liner was put on the market in 2007, about 7,700 of these hip components have been implanted in patients.
According to an article published by Reuters, Smith & Nephew’s decision to withdraw the metal liner came as a result of evidence showing that patients implanted with the hip component experienced higher than normal problems. The recall also came as a result of studies indicating that 1.6 percent of patients with the R3 Acetabular System had to undergo revision surgery each year. This revision rate is higher than the 1 percent guideline put forth by the U.K.’s National Institute for Health and Clinical Excellence.
A spokesperson for Smith & Nephew indicated that patients who had problems with the recalled metal hip liner had experienced dislocations, infections, and fractures. However, the spokesperson stated that there were no indications of metallosis, or metal debris in the body. Although Smith & Nephew stated that the problems associated with its recalled metal liner were different from those associated with all-metal implants, this recent recall reinforces the growing concern with metal-on-metal hips.
See the full Smith & Nephew press release at:
http://global.smith-nephew.com/master/40912.htm
See the full Reuters article at:
http://www.reuters.com/article/2012/06/01/us-smithnephew-hip-idUSBRE85010J20120601
Hurt in a dangerous drugs & devices situation?
Talk directly with John David Hart — board-certified Texas trial lawyer. Free, confidential, no fee unless we win.
Get a Free Case Review Call 817-870-2102More on Dangerous Drugs & Devices
How we handle Dangerous Drugs & Devices →Good News for EpiPen® Auto-Injector Users and Families!
Mylan today issued a statement announcing that it is taking immediate action to increase access to EpiPen® Auto-Injectors by expanding already existing…
Continue reading »Outrageous
In an August 22, 2016, New York Times article, Tara Parker-Pope and Rachel Rabkin Peachman reported on the steep increase in the…
Continue reading »Is It Possible to Keep Up with Product Recalls?
How do we stay safe and keep our families safe when products we use are recalled for safety reasons? Safety recalls are…
Continue reading »